Occurrence and daily variation of phthalate metabolites in the urine of an adult population.

Phthalates like di-(2-ethylhexyl) phthalate (DEHP) are commonly used as plasticizers and their metabolites are suspect of especially reproductive toxicity. The aim of our study was to assess phthalate exposure in adults by measuring urinary phthalate metabolite levels and to explore individual temporal variability. Urine samples were collected by 27 women and 23 men aged 14-60 years during 8 consecutive days. We quantified four monoesters, four oxidative DEHP metabolites, and two secondary metabolites of di-isononyl phthalate (DiNP) by a LC/LC-MS/MS method. If we analyzed all 399 available samples independent of classification, the highest median values of primary metabolites in this study were found for mono-n-butyl phthalate (MnBP: 49.6 microg/l), followed by mono-isobutyl phthalate (MiBP: 44.9 microg/l), mono-benzyl phthalate (MBzP: 7.2 microg/l), and mono-2-ethylhexyl phthalate (MEHP: 4.9 microg/l). The median concentrations of the oxidized metabolites of DEHP were 8.3 microg/l for mono-(2-carboxymethylhexyl) phthalate (2cx-MMHP), 19.2 microg/l for mono-(2-ethyl-5-hydroxyhexyl) phthalate (5OH-MEHP), 14.7 microg/l for mono-(2-ethyl-5-oxohexyl) phthalate (5oxo-MEHP), and 26.2 microg/l for mono-(2-ethyl-5-carboxypentyl) phthalate (5cx-MEPP). The concentrations of the two DiNP secondary metabolites mono (oxoisononyl) phthalate (oxo-MiNP) and mono(hydroxyisononyl) phthalate (OH-MiNP) ranged from <LOD to 304 microg/l (median: 3.0 microg/l, 2.9 microg/g creatinine) and <LOD to 698 microg/l (median: 5.5 microg/l, 5.2 microg/g creatinine), respectively. Phthalate metabolite levels did not consistently differ by sex or age. There was substantial day-to-day variation of urinary levels with considerable within-subject variability. Intraclass correlation coefficients adjusted for sex and age ranged between 0.21 and 0.48 for unadjusted metabolite levels and between 0.20 and 0.57 for creatinine-adjusted levels. The secondary metabolites of DiNP were detectable in nearly all samples and were therefore sensitive biomarkers of DiNP exposure. Our results of within-subject variability suggest that exposure assessment should not be based on a single urine measurement.

[1]  H. Itoh,et al.  Evaluation of the effect of governmental control of human exposure to two phthalates in Japan using a urinary biomarker approach. , 2005, International journal of hygiene and environmental health.

[2]  J. Ambroso,et al.  Developmental toxicity of di-isodecyl and di-isononyl phthalates in rats. , 1999, Reproductive toxicology.

[3]  Dana B Barr,et al.  Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. , 2003, Environmental health perspectives.

[4]  Ian T. Cousins,et al.  Assessment of Critical Exposure Pathways , 2003 .

[5]  D. Baird,et al.  Reproducibility of urinary phthalate metabolites in first morning urine samples. , 2002, Environmental health perspectives.

[6]  L L Needham,et al.  Levels of seven urinary phthalate metabolites in a human reference population. , 2000, Environmental health perspectives.

[7]  Antonia M. Calafat,et al.  Temporal Variability of Urinary Phthalate Metabolite Levels in Men of Reproductive Age , 2004, Environmental health perspectives.

[8]  B. Lake,et al.  A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. , 1999, Regulatory toxicology and pharmacology : RTP.

[9]  J. Angerer,et al.  Biological monitoring of the five major metabolites of di-(2-ethylhexyl)phthalate (DEHP) in human urine using column-switching liquid chromatography-tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  T. Lovekamp-Swan,et al.  Mechanisms of phthalate ester toxicity in the female reproductive system. , 2002, Environmental health perspectives.

[11]  Robert F. Herrick,et al.  Phthalate Exposure and Human Semen Parameters , 2003, Epidemiology.

[12]  A. Calafat,et al.  Oxidative Metabolites of Diisononyl Phthalate as Biomarkers for Human Exposure Assessment , 2006, Environmental health perspectives.

[13]  U. Magnusson,et al.  Kinetics of orally administered di(2-ethylhexyl) phthalate and its metabolite, mono(2-ethylhexyl) phthalate, in male pigs , 2004, Archives of Toxicology.

[14]  J. J. Freeman,et al.  Two-generation reproduction study in rats given di-isononyl phthalate in the diet. , 2000, Reproductive toxicology.

[15]  Russ Hauser,et al.  Medications as a source of human exposure to phthalates. , 2004, Environmental health perspectives.

[16]  H. Dirven,et al.  Metabolites of the plasticizer di (2-ethylhexyl) phthalate in urine samples of workers in polyvinylchloride processing industries , 1993, International archives of occupational and environmental health.

[17]  R. Kruse,et al.  Decrease in Anogenital Distance among Male Infants with Prenatal Phthalate Exposure , 2005, Environmental health perspectives.

[18]  C. Schlatter,et al.  Excretion and metabolism of di(2-ethylhexyl)phthalate in man. , 1985, Xenobiotica; the fate of foreign compounds in biological systems.

[19]  Benson T Akingbemi,et al.  Phthalate-induced Leydig cell hyperplasia is associated with multiple endocrine disturbances. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  V. Valli,et al.  Subchronic oral toxicity of di-n-octyl phthalate and di(2-Ethylhexyl) phthalate in the rat. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[21]  J. Klaunig,et al.  Comparative in vivo hepatic effects of Di-isononyl phthalate (DINP) and related C7-C11 dialkyl phthalates on gap junctional intercellular communication (GJIC), peroxisomal beta-oxidation (PBOX), and DNA synthesis in rat and mouse liver. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  A. Calafat,et al.  Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. , 2003, Environmental health perspectives.

[23]  K. Shea.  Pediatric exposure and potential toxicity of phthalate plasticizers. , 2003, Pediatrics.

[24]  A. Calafat,et al.  Urinary oxidative metabolites of di(2-ethylhexyl) phthalate in humans. , 2006, Toxicology.

[25]  R. H. Mckee,et al.  Absorption, disposition and metabolism of di‐isononyl phthalate (DINP) in F‐344 rats , 2002, Journal of applied toxicology : JAT.

[26]  H Rüden,et al.  Occurrence of phthalates and musk fragrances in indoor air and dust from apartments and kindergartens in Berlin (Germany). , 2004, Indoor air.

[27]  A. Calafat,et al.  PHTHALATES AND HUMAN HEALTH , 2005, Occupational and Environmental Medicine.

[28]  P. Albro,et al.  Metabolism of diethylhexyl phthalate by rats. Isolation and characterization of the urinary metabolites. , 1973, Journal of chromatography.

[29]  A. Calafat,et al.  Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. , 2004, Environmental health perspectives.

[30]  Holger M Koch,et al.  Internal exposure of the general population to DEHP and other phthalates--determination of secondary and primary phthalate monoester metabolites in urine. , 2003, Environmental research.

[31]  Antonia M. Calafat,et al.  Use of Di(2-ethylhexyl) Phthalate–Containing Medical Products and Urinary Levels of Mono(2-ethylhexyl) Phthalate in Neonatal Intensive Care Unit Infants , 2005, Environmental health perspectives.

[32]  J. Angerer,et al.  DEHP metabolites in urine of children and DEHP in house dust. , 2004, International journal of hygiene and environmental health.

[33]  Holger M. Koch,et al.  Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP , 2004, Archives of Toxicology.

[34]  L. Hagmar,et al.  Urinary Phthalate Metabolites and Biomarkers of Reproductive Function in Young Men , 2005, Epidemiology.

[35]  M. Wensing,et al.  Plastics additives in the indoor environment--flame retardants and plasticizers. , 2005, The Science of the total environment.

[36]  A. Calafat,et al.  Determination of 16 phthalate metabolites in urine using automated sample preparation and on-line preconcentration/high-performance liquid chromatography/tandem mass spectrometry. , 2005, Analytical chemistry.

[37]  Antonia M. Calafat,et al.  Personal Care Product Use Predicts Urinary Concentrations of Some Phthalate Monoesters , 2005, Environmental health perspectives.

[38]  J. Klaunig,et al.  Effects of di-isononyl phthalate, di-2-ethylhexyl phthalate, and clofibrate in cynomolgus monkeys. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[39]  Ibrahim Chahoud,et al.  Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets. , 2004, Toxicology and applied pharmacology.

[40]  Holger M Koch,et al.  Internal exposure of nursery-school children and their parents and teachers to di(2-ethylhexyl)phthalate (DEHP). , 2004, International journal of hygiene and environmental health.